Overview


According to FutureWise analysis the market for Pharmaceutical Elixir is expected to register a CAGR of 9.20% from 2023-2031.

An elixir sweet liquid is used to treat medical conditions. It can be taken orally and is intended to heal one's disease. An elixir is a pharmaceutical preparation that contains at least one active component. It can be taken orally. Elixirs have a lower viscosity than syrups because they are less sugary and contain fewer viscosity enhancers. Elixirs are mostly made up of liquid components, with very few excipients that must be dissolved. They are therefore easier to prepare than syrups. However, they are more easily prepared than syrups due to their high alcohol content. Elixirs are when used in pharmaceutical preparation. Each active ingredient contains at least one active component and is intended to be taken orally. Hydro-alcoholic solutions such as Elixir are available. The alcohol is used to prevent crystallization of sugar, preserve finished product, and solubilize it These pharmaceutical excipients enhance the flavor of the product. Sedatives such as medicated elixirs can be used frequently. Antihistamines and expectorants are also available. There are also pediatric elixirs, such as cholatehydrate.
This has limited availability. The use of sedative and hypnotic pharmaceutical drugs. In the pharmaceutical industry, there is a rising demand for nonmedicated remedies. This is why this factor is driving the growth of the Pharmaceutical elixir Market People who have allergies frequently use antihistaminic remedies. As a result, the number of people suffering from allergies is increasing. The rise in demand for pharmaceutical elixirs is due to allergies. Pharmaceutical elixirs can also be used to induce sleep and drowsiness.

These elixirs are beneficial for people with a history of insomnia. Many people suffer from insomnia. This has led to the rise of the pharmaceutical elixir market. But, some pharmaceutical elixirs may contain alcohol which can be harmful for children. Pharmaceutical elixirs can also contain alcohol, which is not good for pediatric patients. Elixirs must be stored in sealed screw-top containers that are watertight. These containers can not be cost-effective. These are just a few of the many factors that can affect your ability to make an informed decision.
Inhibit the growth in the market for pharmaceutical elixirs The growth of the pharmaceutical industry is expected to be boosted by rising cases of patients suffering from different types of allergies. market. These patients are being given antihistaminic remedies, which can be used to treat their symptoms. You can relieve symptoms such as watery eyes, itchy eyes, and runny nasal passages. There are programmes for research and development in many developing nations. Pharmaceutical elixir formulations and indications are anticipated to boost market expansion. Forecast timeframe. The output of medicines has decreased as a result of the outbreak. The market for prescription elixirs.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Pharmaceutical Elixir Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Pharmaceutical Elixir Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Joshnson & Johnson
  • F.Hoffmann-La Roche
  • Merck & Co
  • Bayer AG
  • Pfizer Inc
  • Indivior PLC
  • Alkermes PLC
  • Teva Pharmaceutical Industries Ltd
  • Novartis AG
  • Omeros Corporation

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Type

  • Non-Medicated Elixirs
    • Aromatic Elixirs
    • Isoalcoholic Elixirs
    • Compound Benzaldehyde Elixirs
  • Medicated Elixirs
    • Antithistaminic Elixirs
    • Chlorpheniramine Maleate
    • Diphenhydramine HCI
    • Sedative And Hynotic Elixirs
    • Pediatric Elixirs
    • Chloral Hydrate
    • Expectorant Elixirs
    • Terpin Hydrate

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Sales

By End-User

  • Hospitals
  • Clinics
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Pharmaceutical Elixir Market By Type, By Distribution Channel, By End-User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Pharmaceutical Elixir Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Pharmaceutical Elixir Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Pharmaceutical Elixir Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Pharmaceutical Elixir Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Non-Medicated Elixirs
         1.1. Aromatic Elixirs
         1.2. Isoalcoholic Elixirs
         1.3. Compound Benzaldehyde Elixirs
        2. Medicated Elixirs
         2.1. Antithistaminic Elixirs
         2.2. Chlorpheniramine Maleate
         2.3. Diphenhydramine HCI
         2.4. Sedative And Hynotic Elixirs
         2.5. Pediatric Elixirs
         2.6. Chloral Hydrate
         2.7. Expectorant Elixirs
         2.8. Terpin Hydrate

  • 8.   Pharmaceutical Elixir Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Sales

  • 9.   Pharmaceutical Elixir Market, By End-User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Clinics
        3. Others

  • 10.   North America Pharmaceutical Elixir Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Pharmaceutical Elixir Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Pharmaceutical Elixir Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Pharmaceutical Elixir Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Joshnson & Johnson
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. F.Hoffmann-La Roche
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Merck & Co
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Bayer AG
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Pfizer Inc
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Indivior PLC
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Alkermes PLC
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Teva Pharmaceutical Industries Ltd
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Novartis AG
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Omeros Corporation
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients